Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Multitude Therapeutics Announces Promising Interim Phase I/II Results from the Ongoing First-in-Human Study Evaluating its CD44v9-directed Antibody-Drug-Conjugate, AMT-116, in Heavily Pretreated EGFR Wild-type Non-Small Cell Lung Cancer (NSCLC) and Other Advanced Solid Tumors at the 2025 ESMO Annual Meeting
2025-10-17 22:00
NYSE Content Advisory: Pre-Market Update + Automakers await 5-year tariff relief extension
2025-10-17 20:55
Kelun-Biotech's Core product Trastuzumab Botidotin Approved for Marketing by NMPA for HER2-positive BC
2025-10-17 20:22
One Heung Kong released the White Paper on Global Sustainable and Healthy Living Environments jointly with other institutions
2025-10-17 18:39
One Heung Kong Leads the Way! New Global Benchmark for Healthy Living Announced
2025-10-17 18:35
HMI Medical Signs MOA With Ibraco Berhad To Acquire Land For The Establishment Of Its Third Hospital In Malaysia
2025-10-17 16:49
RITFIT Supports Breast Cancer Awareness Through Fitness at Making Strides Against Breast Cancer Walk
2025-10-17 16:11
Chula Launches Newborn Genome Sequencing Project for Early Detection and Prevention of Genetic Diseases
2025-10-17 16:00
I-Mab Announces Intention to Undertake Strategic Transformation to Global Biotech Platform, to Pursue Hong Kong IPO, and Rebrand as NovaBridge Biosciences
2025-10-17 15:21
/C O R R E C T I O N -- Siemens Healthineers/
2025-10-17 14:49
FDA approves expanded pediatric indications for YUFLYMA® (adalimumab-aaty) and unbranded adalimumab-aaty in the United States
2025-10-17 13:32
Wang Qunbin: Innovation-Driven, Fosun's Path to Globalization
2025-10-17 11:17
Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot
2025-10-17 09:45
Invetech Wins 2025 Australian Good Design Award Gold for Excellence in Design and Innovation
2025-10-17 05:17
MacuMira and Keeler announce global partnership to expand Dry AMD therapy
2025-10-17 04:35
A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan
2025-10-16 23:00
Clarity signs copper-67 Supply Agreement with Nusano
2025-10-16 21:04
Volpara Earns ACR® Learning Network Vendor Partner Designation
2025-10-16 21:00
NYSE Content Advisory: Pre-Market Update + HPE Unveils Strategic Business Priorities
2025-10-16 20:55
Cell Publishes Breakthrough Research Results of IASO Bio's Anti-BCMA CAR-T Equecabtagene Autoleucel in Autoimmune Disease Multiple Sclerosis
2025-10-16 20:45